⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3562422 | 0.73 | ADORA2A (0.36) | — | |
| SCHEMBL8887683 | 0.69 | ESR1 (0.39) | — | |
| SCHEMBL8889173 | 0.68 | ADORA2A (0.41) | — | |
| SCHEMBL8048 | 0.67 | MAP2K4 (0.33) | — | |
| SCHEMBL16819113 | 0.64 | KDM4E (0.44) | — | |
| SCHEMBL16241024 | 0.64 | MAPT (0.47) | — | |
| SCHEMBL15940278 | 0.64 | KIF11 (0.33) | — | |
| SCHEMBL3455207 | 0.64 | — | — | |
| SCHEMBL2693281 | 0.62 | PRKCI (0.41) | — | |
| SCHEMBL8533 | 0.62 | ADORA2A (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7700601-B2 | Substituted indazoles of formula 1.0 that are kinase inhibitors | SCHERING CORPORATION (US) | 2010-04-20 | — | — | US | disclosed |
| EP-2001870-A2 | KINASE INHIBITORS | SCHERING CORPORATION (US) | 2008-12-17 | — | — | EP | disclosed |
| US-20080021019-A1 | immunodeficiencies, cancers, cardiovascular diseases, endocrine disorders, Parkinson's disease, metabolic diseases, tumorigenesis, Alzheimer's disease, heart disease, diabetes, neurodegeneration, inflammation, kidney disease, atherosclerosis and airway disease; substituted pyrazine compounds | SCHERING CORPORATION | 2008-01-24 | — | — | US | disclosed |
| WO-2007126964-A2 | KINASE INHIBITORS | SCHERING CORPORATION (US) | 2007-11-08 | — | — | WO | disclosed |